Revascularization of Left Main Coronary Artery

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Medicine

Background:

• Left main coronary artery (LMCA) disease affects 5-7% of patients undergoing coronary angiography.
• It is frequently associated with multivessel coronary artery disease (CAD), occurring in 70% of cases.
• Untreated significant LMCA disease carries substantial mortality and morbidity risks.

Purpose of the Study:

• To review the current therapeutic options for Left Main Coronary Artery (LMCA) disease.
• To discuss the comparative roles of Coronary Artery Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) for LMCA revascularization.
• To highlight factors influencing the choice between PCI and CABG.

Main Methods:

• Review of existing literature on LMCA disease management.
• Analysis of clinical outcomes associated with CABG and PCI.
• Consideration of technological advancements and patient-specific factors.

Main Results:

• Coronary Artery Bypass Grafting (CABG) remains the traditional therapy for LMCA disease.
• Percutaneous Coronary Intervention (PCI) is a reasonable alternative, particularly for patients with high surgical risk.
• Improvements in drug-eluting stents, antiplatelet therapies, atherectomy, and IVUS-guidance have enhanced PCI outcomes.

Conclusions:

• The decision between PCI and CABG for LMCA disease involves numerous variables.
• A multidisciplinary heart team approach is recommended for optimal treatment decisions.
• Shared decision-making ensures personalized and effective revascularization strategies for LMCA disease.